Frailty and risk of microvascular complications in patients with type 2 diabetes: a population-based cohort study

[1]  M. Bernal-López,et al.  Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia , 2022, International journal of environmental research and public health.

[2]  E. Huang,et al.  Older Adults , 2021, The Maudsley Trainee Guide to the CASC.

[3]  On Lee,et al.  Associations between grip strength and glycemic control in type 2 diabetes mellitus: an analysis of data from the 2014-2019 Korea National Health and Nutrition Examination Survey , 2021, Epidemiology and health.

[4]  B. Jani,et al.  An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes , 2021, Communications Medicine.

[5]  M. Woodward,et al.  The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial , 2021, Diabetes Care.

[6]  Ling-Na Kong,et al.  The prevalence of frailty among community-dwelling older adults with diabetes: A meta-analysis. , 2021, International journal of nursing studies.

[7]  J. Lewsey,et al.  Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis , 2020, The Lancet. Healthy longevity.

[8]  J. Pell,et al.  Associations between physical frailty and dementia incidence: a prospective study from UK Biobank. , 2020, The Lancet. Healthy longevity.

[9]  H. Yokoyama,et al.  Applications of physical performance measures to routine diabetes care for frailty prevention concept: fundamental data with grip strength, gait speed, timed chair stand speed, standing balance, and knee extension strength , 2020, BMJ open diabetes research & care.

[10]  P. Su,et al.  Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up , 2020, Diabetes Care.

[11]  L. Fried,et al.  Frailty: implications for clinical practice and public health , 2019, The Lancet.

[12]  J. Woo,et al.  Management of frailty: opportunities, challenges, and future directions , 2019, The Lancet.

[13]  Satoshi Ida,et al.  Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis , 2019, Cardiovascular Diabetology.

[14]  Yoshiro Kato,et al.  Diabetic neuropathy , 2019, Nature Reviews Disease Primers.

[15]  M. Levine,et al.  Frailty and Risk of Fractures in Patients With Type 2 Diabetes , 2019, Diabetes Care.

[16]  O. Laosa,et al.  Diabetes and frailty , 2019, Current opinion in clinical nutrition and metabolic care.

[17]  R. Romero-Ortuño,et al.  Delaying and reversing frailty: a systematic review of primary care interventions. , 2018, The British journal of general practice : the journal of the Royal College of General Practitioners.

[18]  J. Pell,et al.  The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. , 2018, The Lancet. Public health.

[19]  K. Chien,et al.  Both pre-frailty and frailty increase healthcare utilization and adverse health outcomes in patients with type 2 diabetes mellitus , 2018, Cardiovascular Diabetology.

[20]  F. Mair,et al.  Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants , 2018, The Lancet. Public health.

[21]  F. McAlister,et al.  Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states , 2018, Cardiovascular Diabetology.

[22]  R. Holle,et al.  Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany , 2018, Diabetes Care.

[23]  P. Heagerty,et al.  Diabetes and CKD in the United States Population, 2009-2014. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[24]  C. Sudlow,et al.  Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population , 2017, American journal of epidemiology.

[25]  H. Florez,et al.  How to prevent the microvascular complications of type 2 diabetes beyond glucose control , 2017, British Medical Journal.

[26]  A. Sinclair,et al.  Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. , 2016, Journal of the American Medical Directors Association.

[27]  Cathie Sudlow,et al.  Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank , 2016, PloS one.

[28]  S. Simpson,et al.  Medication Adherence Affects Risk of New Diabetes Complications , 2016, The Annals of pharmacotherapy.

[29]  Jason P. Fine,et al.  Statistical Primer for Cardiovascular Research Introduction to the Analysis of Survival Data in the Presence of Competing Risks , 2022 .

[30]  D. Mozaffarian.  Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.

[31]  B. Dong,et al.  A Pilot Study of the FRAIL Scale on Predicting Outcomes in Chinese Elderly People With Type 2 Diabetes. , 2015, Journal of the American Medical Directors Association.

[32]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[33]  S. Goh,et al.  Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study , 2013, Diabetology & Metabolic Syndrome.

[34]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[35]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[36]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[37]  S. Hurel,et al.  Microvascular complications: pathophysiology and management. , 2010, Clinical medicine.

[38]  K. Rockwood,et al.  Comparison of the prognostic importance of diagnosed diabetes, co‐morbidity and frailty in older people , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[39]  S. Rubin,et al.  Added Value of Physical Performance Measures in Predicting Adverse Health‐Related Events: Results from the Health, Aging and Body Composition Study , 2009, Journal of the American Geriatrics Society.

[40]  L. Fried,et al.  Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. , 2007, Archives of internal medicine.

[41]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[43]  A. Sinclair,et al.  An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017 , 2017, The Journal of Frailty & Aging.

[44]  Richard W. Bohannon.  Hand‐Grip Dynamometry Predicts Future Outcomes in Aging Adults , 2008, Journal of geriatric physical therapy.